- SG$1.88bn
- SG$1.75bn
- SG$706.92m
- 68
- 46
- 53
- 59
Annual cashflow statement for Raffles Medical, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 60.5 | 64.7 | 83.7 | 144 | 91.1 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 15.1 | 35 | 44.6 | 74.3 | 20.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.3 | -2 | -7.57 | -62 | 39.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 111 | 133 | 160 | 196 | 189 |
| Capital Expenditures | -98.4 | -60.1 | -52.8 | -25.3 | -21.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.51 | -2.13 | 0.605 | 2.47 | 9.53 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -96.9 | -62.2 | -52.2 | -22.8 | -12.4 |
| Financing Cash Flow Items | -4.86 | -6.03 | -7.3 | -6.8 | -5.12 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 31.5 | -20.9 | -46.9 | -184 | -85.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 44.8 | 51.3 | 61.9 | -11.9 | 90.5 |